Bladder carcinomas in patients with neurogenic bladder and urinary schistosomiasis: are they the same tumors?

[1]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[2]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[3]  B. Baumann,et al.  Urinary schistosomiasis and the associated bladder cancer: update , 2020, Journal of the Egyptian National Cancer Institute.

[4]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[5]  F. Brimo,et al.  Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy , 2018, PloS one.

[6]  M. Hsieh,et al.  Understanding Urogenital Schistosomiasis-Related Bladder Cancer: An Update , 2018, Front. Med..

[7]  Krysta Chaldekas,et al.  STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non–Muscle-Invasive Bladder Cancer , 2018, Clinical Cancer Research.

[8]  O. Cussenot,et al.  Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: A systematic review , 2018, Neurourology and urodynamics.

[9]  Tian Xie,et al.  Inflammatory microenvironment in the initiation and progression of bladder cancer , 2017, Oncotarget.

[10]  J. Magnaval,et al.  Schistosomose urogénitale et cancer , 2017 .

[11]  O. Hammam,et al.  Expression of Epidermal Growth Factor Receptor and Transforming Growth Factor Alpha in Cancer Bladder: Schistosomal and Non-Schistosomal , 2016, Current Urology.

[12]  C. Lopes,et al.  Insight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics , 2016, Tumor Biology.

[13]  A. Wadagni,et al.  Molecular markers and Schistosoma-associated bladder carcinoma: A systematic review and meta-analysis. , 2015, Cancer epidemiology.

[14]  N. Jonjić,et al.  Correlation of tumor-infiltrating lymphocytes with bladder cancer recurrence in patients with solitary low-grade urothelial carcinoma , 2015, Virchows Archiv.

[15]  A. Emran,et al.  Immunohistochemical pattern of T lymphocytes population within bilharzial-associated bladder neoplasm microenvironment , 2015, International journal of immunopathology and pharmacology.

[16]  C. Lopes,et al.  Estrogen-like metabolites and DNA-adducts in urogenital schistosomiasis-associated bladder cancer. , 2015, Cancer letters.

[17]  O. Cussenot,et al.  Forkhead box protein P3 (Foxp3) expression serves as an early chronic inflammation marker of squamous cell differentiation and aggressive pathology of urothelial carcinomas in neurological patients , 2015, BJU international.

[18]  E. Vardar,et al.  Clinical features and outcomes of nontransitional cell carcinomas of the urinary bladder: Analysis of 125 cases , 2015, Urology annals.

[19]  K. Baggerly,et al.  Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. , 2014, Cancer cell.

[20]  M. Rubin,et al.  Frequent truncating mutations of STAG2 in bladder cancer , 2013, Nature Genetics.

[21]  H. Ahmed,et al.  Immunohistochemical expression of COX2 and iNOS in bladder cancer and its association with urinary schistosomiasis among Sudanese patients , 2013, Infectious Agents and Cancer.

[22]  I. Gouda,et al.  Schistosomiasis and bladder cancer: similarities and differences from urothelial cancer , 2012, Expert review of anticancer therapy.

[23]  R. Legallo,et al.  B cell infiltration and lymphonodular hyperplasia in bladder submucosa of patients with persistent bacteriuria and recurrent urinary tract infections. , 2011, The Journal of urology.

[24]  Y. Lotan,et al.  Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder. , 2011, Human pathology.

[25]  R. Hafidh,et al.  Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors , 2009, Journal of experimental & clinical cancer research : CR.

[26]  V. Reuter,et al.  CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma , 2007, Proceedings of the National Academy of Sciences.

[27]  L. Kiemeney,et al.  Epidemiology of Bladder Cancer , 1999, European Urology.

[28]  Jeong Hwan Park,et al.  Tumor, Nodes, Metastases (TNM) Classification System for Bladder Cancer , 2018 .